FR2080551B2 - - Google Patents

Info

Publication number
FR2080551B2
FR2080551B2 FR7017921A FR7017921A FR2080551B2 FR 2080551 B2 FR2080551 B2 FR 2080551B2 FR 7017921 A FR7017921 A FR 7017921A FR 7017921 A FR7017921 A FR 7017921A FR 2080551 B2 FR2080551 B2 FR 2080551B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7017921A
Other languages
French (fr)
Other versions
FR2080551A2 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Priority to FR7017921A priority Critical patent/FR2080551A2/fr
Publication of FR2080551A2 publication Critical patent/FR2080551A2/fr
Application granted granted Critical
Publication of FR2080551B2 publication Critical patent/FR2080551B2/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7017921A 1970-05-15 1970-05-15 Polar-substd. phenyl propanolamines - useful in treatment of cardiac disorders and hypertension Granted FR2080551A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7017921A FR2080551A2 (en) 1970-05-15 1970-05-15 Polar-substd. phenyl propanolamines - useful in treatment of cardiac disorders and hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7017921A FR2080551A2 (en) 1970-05-15 1970-05-15 Polar-substd. phenyl propanolamines - useful in treatment of cardiac disorders and hypertension

Publications (2)

Publication Number Publication Date
FR2080551A2 FR2080551A2 (en) 1971-11-19
FR2080551B2 true FR2080551B2 (en:Method) 1974-05-24

Family

ID=9055632

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7017921A Granted FR2080551A2 (en) 1970-05-15 1970-05-15 Polar-substd. phenyl propanolamines - useful in treatment of cardiac disorders and hypertension

Country Status (1)

Country Link
FR (1) FR2080551A2 (en:Method)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB902617A (en) * 1959-04-22 1962-08-01 Pfizer Ltd Improvements in or relating to therapeutically-active alkylamines

Also Published As

Publication number Publication date
FR2080551A2 (en) 1971-11-19

Similar Documents

Publication Publication Date Title
AR204384A1 (en:Method)
ATA96471A (en:Method)
AU2044470A (en:Method)
AU1473870A (en:Method)
AU1833270A (en:Method)
AU2130570A (en:Method)
AU2085370A (en:Method)
AU1716970A (en:Method)
AU2017870A (en:Method)
AU1517670A (en:Method)
AU442456B2 (en:Method)
FR2080551B2 (en:Method)
AR195465A1 (en:Method)
AU1974970A (en:Method)
AU1872870A (en:Method)
ATA672271A (en:Method)
AU1918570A (en:Method)
AU1881070A (en:Method)
AU2130770A (en:Method)
AU2115870A (en:Method)
AU1086670A (en:Method)
AU1603270A (en:Method)
AU1879170A (en:Method)
AU1004470A (en:Method)
AU1841070A (en:Method)